Ochratoxin A is a mycotoxin produced by Aspergillus ochraceus and is a natural contaminant of mouldy food. We examined the neuroactive potential of ochratoxin A by measuring the changes in the activities of several membrane bound, cytoplasmic and lysosomal enzymes in the brain of adult female rats, following subchronic application of ochratoxin A. The activities of both soluble and membrane bound fractions of ecto-5'nucleotidase, ecto-Ca 
Introduction
The mycotoxin ochratoxin A (OTA), a metabolite produced by Aspergillus and Penicillium spp., has been implicated as a causal agent in the etiology of Balkan endemic nephropaty in humans and in acute ochratoxicosis in agricultural animals (Hult ef a/., 1982) . It has a number of toxic effects in mammals, the most notable of which is nephrotoxicity (Harwig et a/., 1983) . Ochratoxin A is an immunosuppressive, genotoxic and cancerogenic agent, too (see excellent review of Kuiper-Goodman and Scott, 1989) . It could probably cross placenta, due to its hydrophobic structure, and induce teratogenic effects.
Toxicological studies of ochratoxin A are mainly focused on the impairment of renal function (Berndt et a/., 1980; Marquardt and Fröhlich, 1992) . A number of biochemical changes have been described in the proximal kidney tubule after natural or experimental exposure to the toxin (Dirheimer and Creppy, 1991; Gekle et a/., 1993) . Ochratoxin A decreased the rate of protein synthesis and rate of RNA synthesis, most probably by competing with phenylalanine for the enzyme t-RNA synthetase. Inhibition of phenylalanine hydroxylase and other enzymes that use phenylalanine as substrate is based on the structural homology of ochratoxin A with that amino acid (Creppy et a/., 1990) . Recently it was found that ochratoxin A greatly enhances rate of NADPH dependent lipid peroxidation, both in vivo and in vitro. Enhanced peroxidation of polyunsaturated fatty acids from membrane lipids might seriously impair cell membrane integrity, and produces structural and functional changes, eventually leading to cellular necrosis (Omar ef a/., 1990) . Rahimtula etal. (1988) suggested this mechanism as the possible basis for the toxic effects of OTA.
Neurotoxicological investigations of ochratoxin A are more limited in number, yet histopathological changes and neurological dysfunction have been observed in the exposed animals. CMS appears to be the most susceptible target for ochratoxin A, at the time of early organogenesis, as was shown by teratogenic studies. It has been shown that ochratoxin A and several other mycotoxins, including peritrem A, aflatoxin B^ citrinin and zearalenon, accumulate in the brain and produce changes in the level of acetylcholine (Hukovic and Potkonjak, 1977) . A lower degree of oxidative metabolism in chicken brain has been attributed to ochratoxin A treatment (Pepeljnjak et a/., 1982) . However, these effects were produced by high, almost lethal doses of toxin. Postnatal developmental delay, behavioural changes (Poppe etal., 1983) and abnormalities in the cerebellum were seen in neonatal mice that were exposed to ochratoxin A (Fukui et a/., 1987) . These findings indicate that ochratoxin A is a potent developmental neurotoxin. Long term exposure to ochratoxin A in food would eventually lead to its accumulation in the organism, and thus may cause changes in the adult brain as well. It has been shown that ochratoxin A treatment may produce alterations in the organisation of the lipids in the cell membrane, thus particularly affecting the activities of the membrane bound enzymes.
This study was designed to examine possible alterations in the activities of several membrane bound, cytoplasmic and lysosomal enzymes in the brain of adult female rats, following subchronic application of ochratoxin A. The dose applied corresponds to the concentration that may be encountered in naturally contaminated food products (1.5 ppm per day) (Scott ef a/., 1972) . We examined the activities of both soluble and membrane bound fractions of ecto-5'nucleotidase (EC 3.6.1.5), ectoCa 2 VMg 2 +ATPase (EC 3.6.1.15), gamma-glutamyl transferase (EC 2.3.2.2) and alanine aminopeptidase (EC 3.4.11.2) . These enzymes were chosen as indicators of membrane stability. Activity of N-acetyl-beta-D-glucosaminidase (EC 3.2.1.30) reflects changes in lysosomal and lactate dehydrogenase (EC 1.1.1.27) in cytosolic compartment. Enzyme activities were examined in cerebral cortex, cerebellum and hippocampus, in order to test whether some areas of the brain are preferentially sensitive to ochratoxin A treatment, as previously suggested.
Results
In the preliminary experiments we found detectable concentration of ochratoxin A in the brain, following 5 weeks of daily oral application of low doses of ochratoxin A to female Fisher rats. When inspected under UV light, brain tissue showed fluorescence, which is characteristic for the ochratoxin A presence (results not shown). The serum level of ochratoxin A was measured according to Hult et al. (1982) and was found to be 285 ± 16 ng/ml, following 35 days of treatment. Table 1 presents the distribution of the selected enzyme activities in the brain regions of control rats. In order to test whether distribution of the catalytic concentrations of the selected enzymes differ between the brain regions, we performed the Friedmann test for the simultaneous comparison of all parameters. Activities of lactate dehydrogenase and N-acetyl-beta-D-glucosaminidase did not show statistically significant difference across the brain regions. However, all membrane derived enzymes, in either soluble or particulate form, confirmed our choice.
Membrane-Bound Enzymes
Ecto-5'Nucleotidase Ochratoxin A treatment induced significant increase in the activity of membrane-bound form of ecto-5'nucleotidase (Figure 1 A) . A substantial increase was observed already after 10 days of treatment. The activities stayed high at 20 days and returned to control values after 35 days of treatment. The effects appeared to be regionally selective; the increase in the enzyme activities were more pronounced in cerebral cortex and in cerebellum than in the hippocampus. The enzyme in hippocampus showed a gradual increase in the membrane bound fraction and simultaneous decrease in the soluble part. None of the other two regions showed such an reciprocal relationship between the soluble and the membrane bound enzyme.
Ecto-Ca

2
VMg 2 *ATPase Changes in the activity of ecto-Ca^/Mg^ATPase resemble the activities observed with ecto-5'nucleotidase, only the extent was less pronounced ( Figure 1B ). Significant increase in the activity of membrane bound form, amounting to 130-146% of the control values, was observed at day 10 and at day 20 of the treatment, but only in cerebral cortex and cerebellum. However, the values returned to normal levels towards the end of the experiment. Distribution between soluble and particulate fraction appears to be similar in the tissues tested.
Alanine Aminopeptidase Activity of alanine aminopeptidase was moderately affected by ochratoxin A treatment. Significant decrease in membrane bound fraction was observed only in hippocampus ( Figure 1C ). Simultaneous increase in the soluble fraction suggests that partial solubilisation of the enzyme might be induced by the ochratoxin A application. Similar, but less prominent changes were observed in cerebellum, while no changes were observed in the brain cortex in the first 20 days of treatment. Significant decrease to 72% of the control values, for the soluble form of alanine aminopeptidase in cerebral cortex, was observed after 35 days of treatment.
Gamma-Glutamyl Transferase
The first 10 days of treatment did not affect activity of this enzyme, except the moderate decrease of the soluble form in the brain cortex ( Figure 1D ). Significant increase in the activity of soluble and of membrane bound gamma-glutamyl transferase occurred only following 20 days of treatment. The increase was observed in all three regions of brain, and was the highest in soluble fraction of cerebellum (169%, in comparison to the control). At the end of the experiment (35 day) the values returned close to the control levels.
Pattern of changes that was observed with the gammaglutamyl transferase activity was somewhat different as compared to the other enzymes. The most probable reason for the increase of the activity appears to be the induction of the enzyme activities. After the initial drop in the observed values, a steady increase was measured, followed by the final normalisation of the activities.
Cytosolic and Lysosomal Enzymes
Lactate Dehydrogenase Statistically significant increase in the activity of lactate dehydrogenase was observed in all regions, and the changes were visible already at the beginning of the treatment ( Figure 1E ). Further increase after 20 days was limited to the hippocampus and after 35 days all values returned to normal.
N-Acetyl-Beta-D-Glucosaminidase Much to our surprise the greatest increase in the enzyme activity following the first 10 days of treatment was observed with N-acetyl-beta-D-glucosaminidase ( Figure 1F) . The values for cerebral cortex, cerebellum and hippocampus were 173%, 189% and 253% as compared to the controls, respectively. Along the course of the experiment the activities gradually returned to the normal values.
The results obtained showed physiologically significant alterations in the activity of enzymes tested, and the changes appeared to be time-dependent and regionally selective.
Discussion
The present study was undertaken in order to examine the effects of repeated low doses of ochratoxin A on cerebral cortex, cerebellum and hippocampus. We wanted to find out whether biochemical changes that could be measured in the brain are the consequence of non-specific general toxicity of ochratoxin A, or particular areas of the brain are more susceptible than the others. The repeated low dose regimen was applied in order to produce accumulation of the toxin in the brain. It has been well documented that toxin accumulates in the various tissues, as a consequence of the prolonged retention in the circulation, due to is binding to the plasma proteins (Fuchs and Hult, 1992; Hagelberg et al., 1989) . Fuchs ei al. (1988) have shown by autoradiography measurements, that low doses of 14 C-ochratoxin A given to mice could be found in the brain, skin and muscles, already five minutes following i.v. application.
In our previous studies we found that treatment with low doses of ochratoxin A during 20 and 30 days affected activities of gamma-glutamyl transferase, alanine aminopeptidase and alkaline phosphatase in kidney brush border membranes and in the pancreatic tissue (Pepeljnjak et al., 1991; 2anic-Grubisic et a/., 1995) . These time periods were found to be informative for the subchronical regimen of treatment. It was shown by that activities of renal, membrane bound enzymes like gamma-glutamyl transferase, leucine aminopeptidase, and alkaline phosphatase, were significantly reduced following subchronical ochratoxin A treatment.
Data concerning distribution of the enzyme activities in the brain cells are scarce, therefore we had to test whether enzymes were appropriately selected to reflect the changes in the particular brain region. The results presented in Table 1 showed statistically significant differences among specific enzyme activities measured in cerebral cortex, cerebellum and hippocampus for membrane bound enzymes tested. On average, the highest specific activities appeared to be in the cerebellum.
However, the effects of ochratoxin A treatment are presented in Figure 1 (A-F) . Ecto-5'nucleotidase and ecto-Ca 2 VMg 2+ ATPase showed similar patterns of distribution within the brain cortex and cerebellum, and responded to ochratoxin A treatment in the rather analogous way. The same distribution was found by Mayanil et al. (1982) for Mg^ATPase. The physiological function of these enzymes is not fully understood. It is assumed that they may simply regulate extracellular ATP concentration in the vicinity of the plasma membrane (Senior and Hamlyn, 1983) . In a combined action of ecto-Ca 2~7 Mg 2 ""ATPase and ecto-5'nucleotidase, extracellular ATP may be hydrolysed in a stepwise manner to AMP, and eventually to adenosine (Culic et al., 1990) . Both enzymes are glycoproteins and have their catalytic sites oriented towards the extracellular side of the cell membrane. Therefore it appears plausible to assume that action of these two enzymes is in some way concerted. However, increased activities in the membrane bound fraction of both enzymes were observed at the beginning of the experiment and they lasted for 20 days ( Figure 1A and 1B) . The levels returned to normal values in spite of the continuation of the ochratoxin A treatment. Stimulation of the activity of membrane bound ecto-Ca ATPase observed by Yamamoto and Harris (1983) .
Alanine aminopeptidase showed regional differences only in the membrane bound form. Hippocampus appeared to be the most sensitive to ochratoxin A treatment ( Figure 1C ). Substantial increases in the soluble and decrease in the membrane bound form were visible already after 10 days of treatment. Changes were measurable even after 35 days. However, subchronical treatment lasting 35 days induced inverse changes in the cerebral cortex where an increase in the membrane bound form was observed at day 35. This finding indicates that two different isoenzymes, possibly with different functions, might be encountered in the brain. Accordingly, Mantle etal. (1992) described membrane-bound alanine aminopeptidase having different function from the soluble enzyme studied by Hersh (1981) .
Gamma-glutamyl transferase showed the most prominent regional variability with cerebellum, having almost -three times higher activity than the other regions. Similar ι results were obtained by others (Frey etal., 1991) . Soluble * form of gamma-glutamyl transferase has shown different distribution in comparison to the membrane bound form, supporting the hypothesis of two different enzyme forms that have separate functions in the nervous tissue. The significant increase in soluble and membrane-bound form was observed following 20 days of treatment ( Figure 1D ). It appeared that induction of gamma-glutamyl transferase could not reach the greater value, most probably because of the decrease of the DNA and protein synthesis that are produced by the ochratoxin A treatment (Krogh et al., 1988; Kuiper-Goodman and Scott, 1989) . However, control enzyme activities were restored at the end of the experiment.
Results obtained in the present study indicate that ochratoxin A could alter membrane bound enzyme activities, most probably by inducing the perturbation in the structure and function of plasma membranes. It has been already suggested that the main causes of the impairment of membrane integrity are oxidative processes which diminish its fluidity. Khan et al. (1989) have found that lipid peroxidation of polyunsaturated fatty acids has been accompanied by leakage of calcium through the microsomal membranes. Moreover, nephrotoxic effects produced by OTA treatment could be prevented by disintegration of superoxide radicals and of hydrogen peroxide, by external application of Superoxide dismutase and catalase to rats (Baudrimont et al., 1994) .
The other factor that is influencing leakage of enzymes from the damaged cell membrane is mode of the attachment of particular protein to the hydrophobic phospholipide membrane structure. Our results showed an increase in the soluble form of gamma-glutamyl transferase and alanine aminopeptidase across the all regions tested. These enzymes exhibit the simplest form of linking, in which the terminal sequence of hydrophobic amino acids is inserted into the phospholipid bilayer. A more complex system, involving glycan phosphatidylinositol moiety, refers to the attachment of ectoenzymes like 5'-nucleotidase, Ca 2 VMg 2+ ATPase and alkaline phosphatase. These enzymes showed an increase, predominately in the membrane bound fraction. Therefore, the ochratoxin A induced changes in the distribution between the membrane bound and the soluble fraction of the enzyme studied appeared to be more closely related to the mode of enzyme attachment to the cell membrane than to the specificity of the particular brain region.
Activity of N-acetyl-beta-D-glucosaminidase and of lactate dehydrogenase are rather evenly distributed in the regions tested. Similar results were found by Armbruster and Gruemer (1988) , who tested lactate dehydrogenase distribution in 7 regions of rat and cat brain. These results are not surprising, considering the general role of lactate dehydrogenase in the glycolysis in the cell. However, significant increase in the activities of these two enzymes indicates that the toxin is entering into the brain cell already at the beginning of the treatment. Hippocampus appeared to be the most sensitive brain region because the increased enzyme values stayed for 20 days. . In summary, the observed increase in the activity of membrane bound enzymes measured suggests that ochratoxin A is connected with an impairment in the structure and in the function of brain cell membrane. The present results, together with those from other studies indicate that ochratoxin A produces a large increase in the activities of cytosolic and lysosomal enzymes, too (Gharbi et al., 1993; Ngaha, 1985; Larrieu and Galtier, 1985) . The primary effects that are reflected in the increase of the enzyme activities could be subsequently normalised in spite of the continuation of the daily ochratoxin A treatment.
Materials and Methods
Materials
Biosynthesis of ochratoxin A was obtained from culture of Aspergillus sulphureus NRRL 4077 on wheat kernels with 40% humidity. Isolation procedure was essentially according to (Balzer et al., 1978) . The white crystalline material was tested for purity by thin-layer chromatography and then identified as a bright blue fluorescent spot under short wave UV light (Nesheim, 1969) . The concentration of ochratoxin A was determined spectrophotometrically at 333 nm in methanol, assuming an extinction coefficient of 5500 M' 1 cm"
Animals Adult albino female rats of Fisher strain weighing between 150 and 200 g were used for the experiments and housed five per cage. The environment was maintained at the temperature of 21 ± 2 °C and humidity of 50 ± 10% with a 12 light/dark cycle. The animals were given food and water ad libitum, (foodstandard laboratory pellets, declared not to contain mycotoxins, PLIVA d.d., Zagreb, Croatia). Rats were divided into experimental (n = 10) and control (n = 5) groups. Daily dose of ochratoxin A120 pg/kg b.w. (dissolved in a volume of 0.5 ml of 0.051 ΠΊΜ NaHCO 3 ) was administered to experimental animals (n = 10), each morning by gastric intubation. Animals were sacrificed after 10,20 and 35 days of treatment. Total amount of ochratoxin A given was 200 μg, 400 μg, and 720 μg ochratoxin A per animal, respectively. The control animals (n = 5) received daily dose of 0.5ml of 0.051 ITIM NaHCO 3 for 10, 20 and 35 days, respectively.
Isolation of Brain Regions
Rats were sacrificed by cervical dislocation after light aether anaesthesia. The brain was separated into three regions, cerebral cortex, cerebellum and hippocampus. The tissues were homogenised at 4 °C in an Ultra-turax homogenizer in 2 ml of 0.32 M sucrose buffered with 0.05 M Tris-HCI (pH 7.4). The extracts were centrifuged for 10 min at 800 g and supernatant was further centrifuged at 16 000 g for 45 min. Final supernatant was taken for soluble and lysosomal enzyme assays. Pellets containing cell membranes were resuspended in 1 ml of 0.05 ITIM Tris buffer (pH 7.4) and enzymes were solubilized with 0.5% Triton-X100 for 30 min at 5°C. Soluble proteins were separated by further centrifugation at 16000 g for 30 min.
Enzyme Assays Determination of the activities of ectoCa 2 VMg 2+ ATPase and ecto-5'nucleotidase were performed as described previously (Culic et al, 1990) . Briefly, assays were performed in 0.5 ml of reaction medium containing (final concentrations) 50 mM Tris-HEPES pH 7.4,10 mM KCI and inhibitors of other ATPases, 0.1 ΠΊΜ levamisole, 0.1 mM ouabain, 0.1 mM N-ethylmaleimide, 0.1 mM sodium azide, 1 mM MgCI 2 and 0.030 mg of pro-tein. The ATPase reaction was carried out at 37 °C for 15 min and was initiated by adding ATP to a final concentration of 1 ITIM and terminated by adding 0.1 ml of 10% sodium dodecyl sulphate. The liberated inorganic phosphate was measured by the method of Fiske and Subba Row (1925) . Substrate for the determination of ecto-5'nucleotidase activity was 1 mM AMR Alanine aminopeptidase was determined according to Jung and Scholz (1980) with 0.7mM of alanine-beta naphtylamide as substrate, gamma-glutamyl transferase according to Szasz (1969) with gamma-glutamyl-4-nitroanilide as substrate and lactate dehydrogenase with the standard laboratory test reagent (Smith-Kline, Radonja, Croatia). Activity of N-acetyl-beta-D glucosaminidase was assayed according to Brien et a/. (1970) with 1 ΓΠΜ 4-methylumbelliferyl-2-acetamido-2deoxy-beta-D-glucopyranoside as substrate.
Protein concentration was determined according to Bradford (1976) using bovine serum albumin as a standard.
Chemicals All biochemicals, including coenzymes, substrates and enzymes were of analytical grade purchased from Sigma Chem. Co., (St. Louis, Mo, USA), and from Boehringer (Mannheim, Germany).
Statistics The data are presented as mean values ± SD per mg protein. Significance of the difference was tested by MannWhitney U-test. Values were considered significantly different if p < 0,05.
